Immunoglobulin G Immunity to Hepatitis A Virus in Liver Transplant Candidates: A Serosurvey from Iran
暂无分享,去创建一个
B. Geramizadeh | B. Honarvar | Kamran B Lankarani | S. Nikeghbalian | A. Dehghan | Vahid Seifi | H. Salahi | A. Shamsaeefar | Mohammad Hassan Zahedroozegar | M. R. Rouhezamin | S. A. Malek-Hosseini | Mojdeh Khorrami | Saeid Amiri Zadeh Fard
[1] Mohsen Aliakbarpour,et al. Immunity to Hepatitis-A virus: A nationwide population-based seroprevalence study from Iran. , 2020, Vaccine.
[2] E. Yoshida,et al. In-hospital post-transplant acute hepatitis A viral (HAV) infection in a liver transplant recipient who was HAV seropositive pre-transplant , 2019, Saudi journal of gastroenterology : official journal of the Saudi Gastroenterology Association.
[3] R. Tabrizi,et al. Evolution of Liver Transplantation Program in Shiraz, Iran , 2017 .
[4] Michael S. Green,et al. Transmission of Hepatitis A Virus through Combined Liver–Small Intestine–Pancreas Transplantation , 2017, Emerging infectious diseases.
[5] J. M. Oliveira,et al. A Rare Case of Transfusion Transmission of Hepatitis A Virus to Two Patients with Haematological Disease , 2015, Transfusion Medicine and Hemotherapy.
[6] G. Shiha,et al. Seroprevalence of hepatitis A virus infection in patients with chronic liver diseases: Do we need to vaccinate? , 2015 .
[7] Granov Da,et al. EVOLUTION OF LIVER TRANSPLANTATION PROGRAM IN THE RUSSIAN RESEARCH CENTER FOR RADIOLOGY AND SURGICAL TECHNOLOGIES , 2015 .
[8] R. Kelishadi,et al. Systematic review and meta-analysis on the age-specific seroprevalence of hepatitis A in Iran , 2014, Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences.
[9] J. Syrjänen,et al. Obesity and the risk and outcome of infection , 2013, International Journal of Obesity.
[10] B. Ataei,et al. Seroprevalence of Hepatitis A in Patients with Chronic Hepatitis C in Isfahan Province , 2012, International journal of preventive medicine.
[11] Seonwoo Kim,et al. Seroprevalence of anti-HAV among patients with chronic viral liver disease. , 2011, World journal of gastroenterology.
[12] S. Farhang,et al. Prevalence of hepatitis A in Iranian patients with chronic liver disease. , 2008 .
[13] E. Keeffe. Hepatitis A and B superimposed on chronic liver disease: vaccine-preventable diseases. , 2006, Transactions of the American Clinical and Climatological Association.
[14] T. Silveira,et al. Prevalence of hepatitis A antibody in children and adolescents with chronic liver disease , 2002 .
[15] S. Eckstein. Ethical principles for medical research involving human subjects. , 2001, European journal of emergency medicine : official journal of the European Society for Emergency Medicine.
[16] R. Wiesner,et al. Hepatitis A antibodies in liver transplant recipients: Evidence for loss of immunity posttransplantation , 2000, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[17] WHO position paper on hepatitis A vaccines. , 2000, Canada communicable disease report = Releve des maladies transmissibles au Canada.
[18] T. Ferraro,et al. Fulminant hepatitis associated with hepatitis A virus superinfection in patients with chronic hepatitis C. , 1998, The New England journal of medicine.
[19] R. Steele. Fulminant hepatitis associated with hepatitis A virus superinfection in patients with chronic hepatitis C. , 1998, Clinical pediatrics.